Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-02-15

Clinical Trial Update: Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®) [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating iodinated activated charcoal (IodoCarb) for treating Chronic Fatigue Syndrome. The status of the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IodoCarb (iodinated activated charcoal)

Snippet

Sponsor: PharmaLundensis AB | Conditions: Chronic Fatigue Syndrome | Phase 1, Phase 2 | Status: UNKNOWN